May eliminate appropriate candidates
New device looks to be a vital second-line therapy for selected patients
An expert’s take on FDA’s ‘appropriate rationale’ caveat
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy